Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A mitochondrial DNA mutation cosegregates with the pathophysiological U wave.

R Matsuoka1, M Furutani, J Hayashi

  • 1Heart Institute of Japan, Tokyo Women's Medical University, Tokyo, Shinjuku-ku, 1628666, USA. rumiko@imcir.twmu.ac.jp

Biochemical and Biophysical Research Communications
|March 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Third heart sound in hospitalised patients with acute heart failure: insights from the ATTEND study.

International journal of clinical practice·2014
Same author

Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.

Heart (British Cardiac Society)·2008
Same author

Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat.

Xenobiotica; the fate of foreign compounds in biological systems·2002
Same author

[Surgical treatment of Marfan syndrome; late results and new strategy].

Kyobu geka. The Japanese journal of thoracic surgery·2002
Same author

Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.

Journal of cardiovascular pharmacology and therapeutics·2002
Same author

3beta-hydroxy-delta5 -C27-steroid dehydrogenase deficiency: diagnosis and treatment.

Journal of paediatrics and child health·2002

A novel mitochondrial DNA mutation in the ND1 gene (3394) is linked to prolonged QTU intervals, a characteristic of Long QT Syndrome. This finding expands understanding of Long QT Syndrome causes beyond HERG mutations.

Area of Science:

  • Cardiology
  • Genetics
  • Mitochondrial Biology

Background:

  • Long QT Syndrome (LQT2) is typically associated with HERG mutations.
  • Some individuals with LQT2, despite lacking HERG mutations, exhibit prolonged QTU intervals, suggesting other genetic or environmental factors.

Purpose of the Study:

  • To investigate the genetic basis of prolonged QTU intervals in a family with LQT2 who do not carry the HERG mutation.
  • To identify novel genetic factors contributing to Long QT Syndrome phenotypes.

Main Methods:

  • Sequence analysis of mitochondrial DNA (mtDNA) in affected family members.
  • Creation and functional assessment of cybrids with the candidate mutation (ND1 at 3394).
  • Measurement of NADH-CoQ reductase (complex I) activity and oxygen consumption in cybrids.

Related Experiment Videos

Main Results:

  • A candidate pathogenic mutation was identified at position 3394 in the ND1 gene of mtDNA.
  • Cybrids harboring the 3394 mutation showed significantly reduced complex I activity and oxygen consumption.
  • These functional deficits may lead to ATP depletion and increased cytosolic Ca2+, potentially prolonging QTU intervals.

Conclusions:

  • The 3394 mutation in the ND1 gene is pathogenic and a potential cause of prolonged QTU intervals.
  • This mutation may contribute to congenital and acquired Long QT Syndrome phenotypes, including drug-induced forms.
  • Mitochondrial dysfunction represents a novel mechanism underlying Long QT Syndrome.